Hitomi Kaneko Selected Research

Hitomi Kaneko Research Topics

Disease

13	Multiple Myeloma 11/2023 - 04/2014
5	Lymphoma (Lymphomas) 01/2018 - 03/2005
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 07/2017
2	Neoplasms (Cancer) 01/2022 - 01/2015
2	Infections 01/2022 - 01/2015
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2022
1	Monoclonal Gammopathy of Undetermined Significance 05/2022
1	COVID-19 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2020
1	Pancytopenia 01/2016
1	Fibrosis (Cirrhosis) 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Fever (Fevers) 01/2015
1	Multi-centric Castleman's Disease 01/2015
1	Edema (Dropsy) 01/2015
1	Lymphadenopathy 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2013
1	Abscess 01/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2011
1	Stomatitis 12/2011
1	Febrile Neutropenia 12/2011
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2011
1	Cryoglobulinemia 02/2011
1	Hematologic Diseases (Blood Diseases) 01/2010
1	Liver Diseases (Liver Disease) 01/2010
1	Iron Overload 01/2010
1	Transfusion-Related Acute Lung Injury 01/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2009
1	Thrombotic Thrombocytopenic Purpura 02/2007

Drug/Important Bio-Agent (IBA)

7	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2015
4	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2022 - 02/2007
3	pomalidomideIBA 01/2022 - 01/2015
2	isatuximabIBA 01/2022 - 12/2020
2	SteroidsIBA 01/2016 - 01/2009
2	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 04/2014
2	Melphalan (Alkeran)FDA LinkGeneric 04/2014 - 03/2011
1	elotuzumabIBA 01/2023
1	Immunoglobulin M (IgM)IBA 05/2022
1	tirabrutinibIBA 05/2022
1	Inosine Triphosphate (ITP)IBA 05/2022
1	Gemcitabine FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	NucleosidesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	daratumumabIBA 01/2022
1	N(6)-(N-threonylcarbonyl)adenosineIBA 01/2022
1	Guanosine Diphosphate (GDP)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	carfilzomibIBA 01/2022
1	2- methylthio- N6- threonylcarbamoyladenosineIBA 01/2022
1	ixazomibIBA 04/2021
1	Interleukin-2 (IL2)IBA 01/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015
1	tocilizumab (atlizumab)FDA Link 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	Reticulin (Reticular Fiber)IBA 01/2015
1	Pentostatin (Nipent)FDA LinkGeneric 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2011
1	ranimustineIBA 03/2011
1	Etoposide (VP 16)FDA LinkGeneric 03/2011
1	Methotrexate (Mexate)FDA LinkGeneric 02/2011
1	Deferasirox FDA Link 01/2010
1	EnzymesIBA 01/2010
1	IronIBA 01/2010
1	AntibodiesIBA 01/2009
1	thiamine triphosphorate (TTP)IBA 02/2007
1	Vincristine (Oncovin)FDA LinkGeneric 02/2007
1	OX40 LigandIBA 03/2005

Therapy/Procedure

12	Therapeutics 11/2023 - 01/2009
3	Drug Therapy (Chemotherapy) 05/2022 - 03/2011
3	Stem Cell Transplantation 11/2021 - 03/2011
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2018 - 03/2011
1	Intrauterine Devices (Intrauterine Device) 07/2017
1	Radiotherapy 03/2011
1	Chelation Therapy (Therapy, Chelation) 01/2010
1	Erythrocyte Transfusion 01/2010
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2009